Researcher of the Year

This award will be presented to an employee who demonstrates exceptional commitment to research, with significant potential, or actual improved, outcomes for patients or the community.

Professor Dickon Hayne, Head of Urology – Fiona Stanley Fremantle Hospitals Group

Professor Hayne’s commitment to improving treatments and outcomes for bladder cancer – a difficult-to-treat condition with decreasing survival outcomes – is widely acknowledged.

His contribution to clinical knowledge and translation into clinical practice, along with demonstrated evidence from multiple national and international trials, may be key to changing clinical practice for bladder cancer patients.

Professor Hayne is the coordinating primary investigator of a trial studying the efficacy of a treatment regime for high risk, non-muscle invasive bladder cancer. The trial features the world’s largest patient cohort investigating this condition and could change how the disease is managed globally. Other research activity includes developing trials in the emerging field of theranostics – a novel way of combining diagnostic imaging techniques with delivering therapy agents.

Dedicated to consumer engagement, Professor Hayne also encourages medical and nursing staff to undertake research to improve service delivery and patient outcomes, and mentors junior medical staff.

Congratulations to our other 2022 finalists:

• Helen Keen, Head of Rheumatology – Fiona Stanley Fremantle Hospitals Group
• Kate Maslen, Haematology Clinical Trial Coordinator – Fiona Stanley Fremantle Hospitals Group

View our finalists

See other 2022 SMHS Excellence Award winners.